Skip to content
Catalyst

NAD(+)Papers

Indexed under NAD(+) in PubMed's chemical list

papers
209
40 years, by papers

Newest first

1 to 50 of 209
  • Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial.

    American journal of cardiovascular drugs2026PMID 40954388Also indexed under NAD(+) as a PubMed major topic

  • NAD+ Enhanced on Hearing Recovery in Sudden Sensorineural Hearing Loss: Randomized Controlled Trial.

    The Laryngoscope2026PMID 41035311Also indexed under NAD(+) as a PubMed major topic

  • Association between blood nicotinamide adenine dinucleotide levels and blood laboratory parameters at baseline and after nicotinamide mononucleotide supplementation in middle-aged healthy individuals: post hoc analysis of a randomized, double-blinded, placebo-controlled clinical trial.

    GeroScience2026PMID 41162813Also indexed under NAD(+) as a PubMed major topic

  • Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration.

    Journal of the peripheral nervous system2026PMID 41502156

  • The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans.

    Nature metabolism2026PMID 41540253Also indexed under NAD(+) as a PubMed major topic

  • NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence.

    Ageing research reviews2026PMID 41655607Also indexed under NAD(+) as a PubMed major topic

  • NAD+ augmentation by nicotinamide riboside engages SLIT2/ROBO1 signaling to attenuate Th17 inflammation in psoriasis.

    JCI insight2026PMID 42048163Also indexed under NAD(+) as a PubMed major topic

  • A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD.

    Journal of Crohn's & colitis2026PMID 42223054Also indexed under NAD(+) as a PubMed major topic

  • A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment.

    Alzheimer's & dementia2026PMID 42478598

  • Integrative functional bioinformatic analysis of NAD+-associated protein coding genes in adipose tissue (dys)function - evidence from targeted rodent transcriptomic studies.

    Frontiers in endocrinology2026PMID 42553099Also indexed under NAD(+) as a PubMed major topic

  • NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives.

    Frontiers in neurology2026PMID 42877680Also indexed under NAD(+) as a PubMed major topic

  • Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials.

    Critical reviews in food science and nutrition2025PMID 39116016

  • Acute exercise boosts NAD+ metabolism of human peripheral blood mononuclear cells.

    Brain, behavior, and immunity2025PMID 39500416Also indexed under NAD(+) as a PubMed major topic

  • Interactions between NAD+ metabolism and immune cell infiltration in ulcerative colitis: subtype identification and development of novel diagnostic models.

    Frontiers in immunology2025PMID 39975557Also indexed under NAD(+) as a PubMed major topic

  • Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review.

    Frontiers in immunology2025PMID 40529366

  • Identification of potential NAD-related biomarkers of recurrent miscarriage risk.

    Human reproduction (Oxford, England)2025PMID 41170824Also indexed under NAD(+) as a PubMed major topic

  • Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review.

    American journal of physiology2024PMID 37971292Also indexed under NAD(+) as a PubMed major topic

  • A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment.

    GeroScience2024PMID 37994989Also indexed under NAD(+) as a PubMed major topic

  • Enhancing l-Malic Acid Production in Aspergillus niger via Natural Activation of sthA Gene Expression.

    Journal of agricultural and food chemistry2024PMID 38407053

  • Efficient synthesis of L-malic acid by malic enzyme biocatalysis with CO2 fixation.

    Bioresource technology2024PMID 38777233

  • Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.

    GeroScience2024PMID 38789831Also indexed under NAD(+) as a PubMed major topic

  • Novel insight into nicotinamide adenine dinucleotide and related metabolites in cancer patients undergoing surgery.

    Scientific reports2024PMID 39019993Also indexed under NAD(+) as a PubMed major topic

  • Effects of Supplementation with NAD + Precursors on Metabolic Syndrome Parameters: A Systematic Review and Meta-Analysis.

    Hormone and metabolic research2024PMID 39111741Also indexed under NAD(+) as a PubMed major topic

  • Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach.

    Journal of Alzheimer's disease2024PMID 39422945Also indexed under NAD(+) as a PubMed major topic

  • Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.

    Nature aging2024PMID 39548320

  • MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults.

    The journals of gerontology2023PMID 35182418Also indexed under NAD(+) as a PubMed major topic

  • The HF-AF ENERGY Trial: Nicotinamide Riboside for the Treatment of Atrial Fibrillation in Heart Failure Patients.

    Cardiovascular drugs and therapy2023PMID 36227441

  • Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study.

    Geriatrics & gerontology international2023PMID 36443648

  • The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.

    GeroScience2023PMID 36482258Also indexed under NAD(+) as a PubMed major topic

  • Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin.

    Aging cell2023PMID 36515353

  • Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study.

    Science advances2023PMID 36638183Also indexed under NAD(+) as a PubMed major topic

  • Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study.

    The Journal of clinical endocrinology and metabolism2023PMID 36740954

  • Meta-analysis of NAD(P)(H) quantification results exhibits variability across mammalian tissues.

    Scientific reports2023PMID 36774401Also indexed under NAD(+) as a PubMed major topic

  • Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.

    Scientific reports2023PMID 36797393

  • ATP and NAD+ Deficiency in Parkinson's Disease.

    Nutrients2023PMID 36839301

  • Nicotinamide mononucleotides alleviated neurological impairment via anti-neuroinflammation in traumatic brain injury.

    International journal of medical sciences2023PMID 36860678

  • Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease.

    Oxidative medicine and cellular longevity2023PMID 36865349

  • Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.

    The journals of gerontology2023PMID 37068054Also indexed under NAD(+) as a PubMed major topic

  • Dysregulated cellular redox status during hyperammonemia causes mitochondrial dysfunction and senescence by inhibiting sirtuin-mediated deacetylation.

    Aging cell2023PMID 37101412

  • Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators.

    Free radical biology & medicine2023PMID 37245532

  • Exercise training upregulates intracellular nicotinamide phosphoribosyltransferase expression in humans: a systematic review with meta-analysis.

    Frontiers in public health2023PMID 37954044Also indexed under NAD(+) as a PubMed major topic

  • Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.

    Nature structural & molecular biology2023PMID 37957306

  • NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease.

    Nature communications2023PMID 38016950

  • Effect of Nicotinamide Mononucleotide Concentration in Human Milk on Neurodevelopmental Outcome: The Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.

    Nutrients2023PMID 38201974

  • Reduced Levels of NAD in Skeletal Muscle and Increased Physiologic Frailty Are Associated With Viral Coinfection in Asymptomatic Middle-Aged Adults.

    Journal of acquired immune deficiency syndromes (1999)2022PMID 35015741

  • Blockage of citrate export prevents TCA cycle fragmentation via Irg1 inactivation.

    Cell reports2022PMID 35172156

  • The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.

    Cell metabolism2022PMID 35235774Also indexed under NAD(+) as a PubMed major topic

  • Sirtuins in atherosclerosis: guardians of healthspan and therapeutic targets.

    Nature reviews. Cardiology2022PMID 35354967

  • Regulation of SIRT1 and Its Roles in Inflammation.

    Frontiers in immunology2022PMID 35359990

  • Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.

    Journal of advanced research2022PMID 35499054

The next 50 papers

Every paper about NAD(+)